PlainRecalls
FDA Drug Moderate Class II Ongoing

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30

Reported: June 26, 2024 Initiated: May 23, 2024 #D-0555-2024

Product Description

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30

Reason for Recall

Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

Details

Recalling Firm
Eugia US LLC
Units Affected
70,125 vials
Distribution
USA Nationwide
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30. Recalled by Eugia US LLC. Units affected: 70,125 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 26, 2024. Severity: Moderate. Recall number: D-0555-2024.